Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 43c ; Offers Guidance

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.04, $0.43 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $76.2 million versus the consensus estimate of $74.87 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2025 EPS of ~($0.65), versus the consensus of ($0.37). Fulgent Genetics, Inc. sees FY2025 revenue of ~$310 million, versus the consensus of $324 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• AeroVironment restates quarterly financials, citing $89M goodwill error
• ZenaTech raises Plurilock Security stake to 12% with new share purchase